Clear Sleep
Private home sleep apnoea assessment service in the UK based on WatchPAT technology, with algorithmic analysis and review by GMC-registered clinicians.
About Clear Sleep
Home sleep apnoea assessment in the UK
Clear Sleep is a private obstructive sleep apnoea assessment service carried out entirely from the patient's home. Its approach is based on the WatchPAT device, a overnight monitoring device that the company presents as recommended by NICE (National Institute for Health and Care Excellence) for the diagnosis and severity assessment of obstructive sleep apnoea in adults aged 16 and over. The service is available across the UK and requires no GP referral or hospital visit.
A guided five-step pathway
The process begins with an online screening questionnaire that assesses symptoms and suitability before any test is carried out. If the result is favourable, a WatchPAT device is sent to the patient's home for use over a single night in their own bed. The data recorded during sleep is first processed by the device's algorithm and then reviewed and confirmed by a UK-based sleep specialist or physiologist. The company emphasises that this algorithm is the same as that used in NHS sleep services.
After review, the patient receives a clinician-led results call explaining the findings in plain language and guiding them on next steps. Where treatment or further review is required, the service helps patients understand the available options.
Technology and clinical team
Clear Sleep works with the WatchPAT ONE and WatchPAT 300 models from ZOLL Itamar, and has ResMed as its CPAP equipment partner for treatment pathways. The company states that its clinical team is GMC-registered and practises within the NHS, and that every report is reviewed to the same standard applied in NHS sleep services. The review combines automated analysis with professional assessment.
Patient profile
The assessment is intended for people aged over 16 with common signs of disturbed sleep or suspected apnoea: loud snoring, waking unrefreshed, daytime sleepiness, morning headaches, breathing pauses noticed by a partner, persistent fatigue or brain fog. The material highlights that in women apnoea often manifests differently, with ongoing exhaustion and mood changes. It also mentions as candidates those with hypertension or cardiovascular risk factors and those seeking a private assessment without long waiting lists.
Service levels and catalogue prices
The analysed website presented three options, all including the WatchPAT home test and a clinician-reviewed report:
- ClearSleep Essential, £189: home test and clinical report.
- ClearSleep Plus, £399: includes the above plus a 30-minute clinical video consultation.
- ClearSleep Complete, £549: full pathway with medical consultation and CPAP trial.
Final suitability is confirmed after the free screening. These terms correspond to the information published at the time of analysis and may change.
Differentiation from generic tests
The company contrasts its model with conventional online tests: it includes pre-test screening, a specialist-reviewed report, a clinician-led results call and a clear next-step plan. It adds that care is provided in plain language and that the device is posted anywhere in the UK. The service does not replace NHS specialist care and is not intended for medical emergencies.
Location and contact
Phone: 0161 883 7517 · Email: hello@clearsleephealth.co.uk
Home sleep apnoea testing with WatchPAT